Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-15

Clinical Trial Update: Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty [Phase 4]

View source ↗

Summary

This Phase 4 trial compares noninferiority of oral tranexamic acid versus intravenous administration for postoperative hemorrhage and blood loss in total hip ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral tranexamic acid (tranexamic acid)
  • intravenous tranexamic acid (tranexamic acid)

Snippet

Sponsor: University of Liege | Conditions: Hemorrhage Postoperative, Total Blood Loss | Phase 4 | Status: COMPLETED